{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:02:14Z","timestamp":1784044934398,"version":"3.55.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gene.2026.150236","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:55:36Z","timestamp":1780070136000},"page":"150236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Circular RNA\u2013centered regulatory networks in breast cancer: From ceRNA crosstalk to immune microenvironment reprogramming"],"prefix":"10.1016","volume":"1006","author":[{"given":"Junwu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.gene.2026.150236_b0725","article-title":"Sangi Nasab Lahijan a, Rajabi Matak a, Izadi P: Plasma circular RNAs in breast cancer: From biomarker potential to functional significance","volume":"8","author":"Abdollahi","year":"2025","journal-title":"Cancer Reports (hoboken, NJ)"},{"issue":"7","key":"10.1016\/j.gene.2026.150236_b0080","doi-asserted-by":"crossref","first-page":"10080","DOI":"10.1002\/jcp.27941","article-title":"Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer","volume":"234","author":"Abdollahzadeh","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.gene.2026.150236_b0070","article-title":"Multifaceted interactions between lncRNA-associated ceRNA networks and small molecules in triple-negative breast cancer","volume":"189","author":"Alkan","year":"2025","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"20","key":"10.1016\/j.gene.2026.150236_b0580","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204709","article-title":"LPS induces GM-CSF production by breast cancer MDA-MB-231 cells via long-chain Acyl-CoA Synthetase 1","volume":"25","author":"Al-Rashed","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0720","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41420-025-02576-9","article-title":"Circular RNA profiling identifies circ_0001522, circ_0001278, and circ_0001801 as predictors of unfavorable prognosis and drivers of triple-negative breast cancer hallmarks","volume":"11","author":"Awata","year":"2025","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.gene.2026.150236_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: Biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"21","key":"10.1016\/j.gene.2026.150236_b0715","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215444","article-title":"Classic and new markers in diagnostics and classification of breast cancer","volume":"14","author":"Be\u0148a\u010dka","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.gene.2026.150236_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102257","article-title":"Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis","volume":"99","author":"Boman","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"9","key":"10.1016\/j.gene.2026.150236_b0600","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.18632\/oncotarget.3372","article-title":"Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective","volume":"6","author":"Burks","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.gene.2026.150236_b0450","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183656","article-title":"MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor-positive HER2-negative breast cancer","volume":"135","author":"Cai","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0705","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s11033-024-09808-8","article-title":"CircRNA hsa_circ_0003528\/miR-215 is considered a potential target for predictive prognosis and therapy for triple-negative breast cancer","volume":"51","author":"Chang","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"6","key":"10.1016\/j.gene.2026.150236_b0120","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac364","article-title":"Deep learning models for disease-associated circRNA prediction: a review","volume":"23","author":"Chen","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.gene.2026.150236_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154757","article-title":"Glycyrrhetinic acid suppresses breast cancer metastasis by inhibiting M2-like macrophage polarization via activating JNK1\/2 signaling","volume":"114","author":"Cheng","year":"2023","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.gene.2026.150236_b0210","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10517-017-3872-1","article-title":"Search of MicroRNAs regulating the receptor status of breast cancer in silico and experimental confirmation of their expression in Tumors","volume":"163","author":"Chernyi","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molcel.2023.11.033","article-title":"The competitive landscape of the dsRNA world","volume":"84","author":"Cottrell","year":"2024","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0690","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1515\/jtim-2025-0029","article-title":"CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancer","volume":"13","author":"Dai","year":"2025","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.gene.2026.150236_b0330","article-title":"Circ_0105487 promotes the metastasis of triple-negative breast cancer via epithelial-mesenchymal transition","author":"Deng","year":"2025","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0480","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13046-020-01786-6","article-title":"Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion","volume":"40","author":"Fang","year":"2021","journal-title":"J. Experim. Clinical Cancer Res. : CR"},{"issue":"12","key":"10.1016\/j.gene.2026.150236_b0710","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.7150\/ijbs.58916","article-title":"Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a\/BRD4 axis","volume":"17","author":"Fu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11033-023-09172-z","article-title":"Circular RNA and its potential diagnostic and therapeutic values in breast cancer","volume":"51","author":"Gao","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.gene.2026.150236_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.966083","article-title":"The role of CircRNA\/miRNA\/mRNA axis in breast cancer drug resistance","volume":"12","author":"Ghazimoradi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gene.2026.150236_b0335","first-page":"1145","article-title":"Circular RNA DENND4C regulates cell malignant behaviors in breast cancer through the miR-26a-5p\/HSPA8 Axis","volume":"17","author":"Guo","year":"2025","journal-title":"Breast Cancer (dove Med Press)"},{"issue":"4","key":"10.1016\/j.gene.2026.150236_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040312","article-title":"Exploratory review and in silico insights into circRNA and RNA-binding protein roles in \u03b3-globin to \u03b2-globin switching","volume":"14","author":"Habara","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.gene.2026.150236_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155651","article-title":"In silico analysis and comprehensive review of circular-RNA regulatory roles in breast diseases; A step-toward non-coding RNA precision","volume":"263","author":"Hamdy","year":"2024","journal-title":"Pathol. Res. Pract."},{"issue":"10","key":"10.1016\/j.gene.2026.150236_b0370","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1002\/jcb.26767","article-title":"microRNA-30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway","volume":"119","author":"Han","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.gene.2026.150236_b0340","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70499","article-title":"Circular RNA circHSPA8 aggravates metastasis by acting as a competitive inhibitor of miR-195-5p to upregulate WNT3A expression in breast cancer","volume":"29","author":"Han","year":"2025","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.gene.2026.150236_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113774","article-title":"EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions","volume":"155","author":"Hashemi","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"22","key":"10.1016\/j.gene.2026.150236_b0645","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1101\/gad.305862.117","article-title":"RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF","volume":"31","author":"Huang","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.gene.2026.150236_b0675","article-title":"A comprehensive RNA study to Identify circRNA and miRNA biomarkers for docetaxel resistance in breast cancer","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gene.2026.150236_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1162259","article-title":"Identification of circRNA-miRNA-mRNA network in luminal breast cancers by integrated analysis of microarray datasets","volume":"10","author":"Huang","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"7995","key":"10.1016\/j.gene.2026.150236_b0030","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","article-title":"Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides","volume":"625","author":"Huang","year":"2024","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.gene.2026.150236_b0300","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/s41417-025-00943-3","article-title":"Long non-coding RNA PRSS23-AS1 as ceRNA promotes breast cancer progression by regulating EMT via miR-3176 \/YBX1 axis","volume":"32","author":"Huang","year":"2025","journal-title":"Cancer Gene Ther."},{"issue":"4","key":"10.1016\/j.gene.2026.150236_b0240","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ncrna.2024.05.008","article-title":"Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications","volume":"9","author":"Hushmandi","year":"2024","journal-title":"Noncoding RNA Res"},{"issue":"6","key":"10.1016\/j.gene.2026.150236_b0135","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s12276-024-01220-3","article-title":"Molecular mechanisms of circular RNA translation","volume":"56","author":"Hwang","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"4","key":"10.1016\/j.gene.2026.150236_b0215","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.breast.2015.04.001","article-title":"Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease","volume":"24","author":"Inns","year":"2015","journal-title":"Breast"},{"issue":"7\u20138","key":"10.1016\/j.gene.2026.150236_b0035","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1002\/jcp.29558","article-title":"Circular RNA; a new biomarker for breast cancer: A systematic review","volume":"235","author":"Jahani","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0205","doi-asserted-by":"crossref","first-page":"26300","DOI":"10.1038\/s41598-025-11621-7","article-title":"The circDUSP1\/miR-429\/DLC1 regulatory network affects proliferation, migration, and invasion of triple-negative breast cancer cells","volume":"15","author":"Jian","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0440","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12935-023-03111-5","article-title":"Exosomal circRNA RHOT1 promotes breast cancer progression by targeting miR-204-5p\/ PRMT5 axis","volume":"23","author":"Jiang","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0485","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","article-title":"PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol. Cancer"},{"issue":"24","key":"10.1016\/j.gene.2026.150236_b0605","article-title":"HnRNPA2B1 ISGylation regulates m6A-tagged mRNA selective export via ALYREF\/NXF1 complex to foster breast cancer development","volume":"11","author":"Jin","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.gene.2026.150236_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155944","article-title":"The function of circular RNAs in regulating Wnt\/\u03b2-catenin signaling: An innovative therapeutic strategy for breast and gynecological cancers","volume":"270","author":"Kahkesh","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.gene.2026.150236_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154402","article-title":"Hypoxia-circular RNA crosstalk to promote breast cancer","volume":"244","author":"Karami Fath","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.gene.2026.150236_b0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergen.2020.08.005","article-title":"MicroRNAs in breast cancer: New maestros defining the melody","volume":"246\u2013247","author":"Khalife","year":"2020","journal-title":"Cancer Genet."},{"issue":"10","key":"10.1016\/j.gene.2026.150236_b0585","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s43018-021-00254-0","article-title":"Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis","volume":"2","author":"Klemm","year":"2021","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0270","doi-asserted-by":"crossref","first-page":"183","DOI":"10.33594\/000000633","article-title":"Role of O-GlcNAcylation in Breast Cancer Biology","volume":"57","author":"Kozal","year":"2023","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0455","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41746-025-01967-7","article-title":"Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer","volume":"8","author":"Kuang","year":"2025","journal-title":"NPJ Digit Med"},{"issue":"23","key":"10.1016\/j.gene.2026.150236_b0475","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314937","article-title":"Genetic heterogeneity, Tumor microenvironment and immunotherapy in triple-negative breast cancer","volume":"23","author":"Kudelova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.gene.2026.150236_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/cells14060398","article-title":"GATAD2B O-GlcNAcylation regulates breast cancer stem-like potential and drug resistance","volume":"14","author":"Le Minh","year":"2025","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.gene.2026.150236_b0305","doi-asserted-by":"crossref","first-page":"23197","DOI":"10.18632\/oncotarget.8099","article-title":"STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0140","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","article-title":"The Biogenesis, Functions, and challenges of Circular RNAs","volume":"71","author":"Li","year":"2018","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0490","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/or.2020.7831","article-title":"PD\u2011L1\/PD\u20111 blockade in breast cancer: The immunotherapy era (Review)","volume":"45","author":"Li","year":"2021","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.gene.2026.150236_b0680","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41419-023-06006-5","article-title":"circRNA-SFMBT2 orchestrates ER\u03b1 activation to drive tamoxifen resistance in breast cancer cells","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.gene.2026.150236_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108537","article-title":"Proteomic, single-cell and bulk transcriptomic analysis of plasma and tumor tissues unveil core proteins in response to anti-PD-L1 immunotherapy in triple negative breast cancer","volume":"176","author":"Li","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.gene.2026.150236_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123013","article-title":"RNA-binding protein LSM7 facilitates breast cancer metastasis through mediating alternative splicing of CD44","volume":"356","author":"Li","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0665","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-024-02019-6","article-title":"CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K\/AKT\/mTOR activation","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.gene.2026.150236_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2020.100304","article-title":"ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone","volume":"24","author":"Liu","year":"2020","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.gene.2026.150236_b0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2022.05.043","article-title":"Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines","volume":"348","author":"Liu","year":"2022","journal-title":"J. Control. Release"},{"issue":"33","key":"10.1016\/j.gene.2026.150236_b0280","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg7112","article-title":"Zhong X et al: FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer","volume":"9","author":"Liu","year":"2023","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.gene.2026.150236_b0285","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202256458","article-title":"O-GlcNAcylation promotes topoisomerase II\u03b1 catalytic activity in breast cancer chemoresistance","volume":"24","author":"Liu","year":"2023","journal-title":"EMBO Rep."},{"issue":"5","key":"10.1016\/j.gene.2026.150236_b0640","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1109\/TCBB.2023.3272400","article-title":"CRBSP:Prediction of CircRNA-RBP binding sites based on multimodal intermediate fusion","volume":"20","author":"Liu","year":"2023","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinf."},{"key":"10.1016\/j.gene.2026.150236_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1506492","article-title":"The impact of ferroptosis and ferroptosis-related non-coding RNAs on breast cancer progression","volume":"12","author":"Liu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0635","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1109\/JBHI.2024.3354121","article-title":"SSCRB: predicting circRNA-RBP interaction sites using a sequence and structural feature-based attention model","volume":"28","author":"Liu","year":"2024","journal-title":"IEEE J. Biomed. Health Inform."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-025-02254-5","article-title":"Role of circular RNAs in cancer therapy resistance","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.gene.2026.150236_b0365","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.62347\/AMTI5713","article-title":"Circ_0000190 inhibits the progression of triple negative breast cancer by regulating miR-301a\/MEOX2 pathway","volume":"15","author":"Liu","year":"2025","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0565","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2479926","article-title":"CircATP5C1 promotes triple-negative breast cancer progression by binding IGF2BP2 to modulate CSF-1 secretion","volume":"26","author":"Liu","year":"2025","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0435","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12967-022-03728-6","article-title":"Lymphatic metastasis-associated circRNA\u2012miRNA\u2012mRNA network for exploring the pathogenesis and therapeutic target of triple negative breast cancer based on whole-transcriptome sequencing analysis: an experimental verification study","volume":"20","author":"Luo","year":"2022","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.gene.2026.150236_b0095","doi-asserted-by":"crossref","first-page":"e3500","DOI":"10.1002\/jgm.3500","article-title":"Comprehensive analysis of the exosomal circRNA-miRNA-mRNA network in breast cancer","volume":"25","author":"Mao","year":"2023","journal-title":"J. Gene Med."},{"issue":"30","key":"10.1016\/j.gene.2026.150236_b0005","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.2174\/1381612819666131125145517","article-title":"Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence","volume":"20","author":"Mb","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0350","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3892\/ol.2025.15192","article-title":"circEFR3A promotes breast cancer progression by sponging miR-590-3p to upregulate androgen receptor expression","volume":"30","author":"Mi","year":"2025","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.gene.2026.150236_b0535","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","article-title":"Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer","volume":"17","author":"Mu","year":"2018","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.gene.2026.150236_b0160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","article-title":"The therapeutic potential of circular RNAs","volume":"26","author":"O'Leary","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.gene.2026.150236_b0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ymeth.2021.02.020","article-title":"The design and synthesis of circular RNAs","volume":"196","author":"Obi","year":"2021","journal-title":"Methods (san Diego, Calif)"},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0175","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13046-025-03355-1","article-title":"CircPVT1 weakens miR-33a-5p unleashing the c-MYC\/GLS1 metabolic axis in breast cancer","volume":"44","author":"Palcau","year":"2025","journal-title":"J. Experimental & Clinical Cancer Res. : CR"},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0380","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cac2.12138","article-title":"EMT-associated microRNAs and their roles in cancer stemness and drug resistance","volume":"41","author":"Pan","year":"2021","journal-title":"Cancer Commun (lond)"},{"issue":"5","key":"10.1016\/j.gene.2026.150236_b0225","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/2211068214561788","article-title":"Technology in MicroRNA profiling: Circulating MicroRNAs as noninvasive cancer biomarkers in breast cancer","volume":"20","author":"Pimentel","year":"2015","journal-title":"J. Lab. Autom."},{"issue":"5","key":"10.1016\/j.gene.2026.150236_b0230","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s13346-021-00999-2","article-title":"MicroRNAs as therapeutic targets in breast cancer metastasis","volume":"12","author":"Pouya","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0610","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12967-023-04135-1","article-title":"ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma","volume":"21","author":"Qu","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.gene.2026.150236_b0385","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1476-4598-13-200","article-title":"microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer","volume":"13","author":"Rostas","year":"2014","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.gene.2026.150236_b0590","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/0008-5472.CAN-19-2374","article-title":"The immunosuppressive microenvironment in BRCA1-IRIS-overexpressing TNBC Tumors is induced by bidirectional interaction with Tumor-associated macrophages","volume":"80","author":"Sami","year":"2020","journal-title":"Cancer Res."},{"issue":"Pt 2","key":"10.1016\/j.gene.2026.150236_b0075","article-title":"Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review","volume":"266","author":"Saranya","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.gene.2026.150236_b0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.31083\/j.fbl2908287","article-title":"Epigenetic modulations in breast cancer: An emerging paradigm in therapeutic implications","volume":"29","author":"Sarkar","year":"2024","journal-title":"Front Biosci (landmark Ed)"},{"issue":"2","key":"10.1016\/j.gene.2026.150236_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.seminoncol.2025.152340","article-title":"Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression","volume":"52","author":"Sasi","year":"2025","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12864-022-08820-1","article-title":"Prediction of Back-splicing sites for CircRNA formation based on convolutional neural networks","volume":"23","author":"Shen","year":"2022","journal-title":"BMC Genomics"},{"key":"10.1016\/j.gene.2026.150236_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110338","article-title":"Breast cancer derived exosomes promoted angiogenesis of endothelial cells in microenvironment via circHIPK3\/miR-124-3p\/MTDH axis","volume":"95","author":"Shi","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.gene.2026.150236_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108253","article-title":"Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options","volume":"237","author":"So","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0670","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-023-01806-x","article-title":"A novel polypeptide CAPG-171aa encoded by circCAPG plays a critical role in triple-negative breast cancer","volume":"22","author":"Song","year":"2023","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.gene.2026.150236_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110577","article-title":"A non-coding RNA circGNAI2 suppresses triple-negative breast cancer progression by sponging miR-454-3p to inhibit the VGLL4-STAT3 signaling","volume":"301","author":"Song","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0495","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/BD-249006","article-title":"PD-1\/PD-L1 pathway: Current research in breast cancer","volume":"43","author":"Syamsu","year":"2024","journal-title":"Breast Dis."},{"key":"10.1016\/j.gene.2026.150236_b0525","article-title":"Circ_0006174 drives triple negative breast cancer progression and immune escape through regulating miR-3139\/PD-L1 Axis","author":"Tang","year":"2025","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"7483","key":"10.1016\/j.gene.2026.150236_b0055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature12986","article-title":"The multilayered complexity of ceRNA crosstalk and competition","volume":"505","author":"Tay","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.gene.2026.150236_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/biom9100555","article-title":"ACSL1 regulates TNF\u03b1-induced GM-CSF production by breast cancer MDA-MB-231 cells","volume":"9","author":"Thomas","year":"2019","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.gene.2026.150236_b0620","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1038\/s44319-024-00282-8","article-title":"RNA binding protein ZCCHC24 promotes tumorigenicity in triple-negative breast cancer","volume":"25","author":"Uchida","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.gene.2026.150236_b0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ymeth.2021.04.014","article-title":"Methods to study circRNA-protein interactions","volume":"196","author":"Ulsh\u00f6fer","year":"2021","journal-title":"Methods (san Diego, Calif)"},{"issue":"4","key":"10.1016\/j.gene.2026.150236_b0745","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/1878-0261.12468","article-title":"The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment","volume":"13","author":"Verduci","year":"2019","journal-title":"Mol. Oncol."},{"issue":"22","key":"10.1016\/j.gene.2026.150236_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221918","article-title":"LUCAT1-Mediated competing endogenous RNA (ceRNA) network in triple-negative breast cancer","volume":"13","author":"Verma","year":"2024","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0515","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","article-title":"METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer","volume":"21","author":"Wan","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0235","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1631\/jzus.B1400184","article-title":"MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential","volume":"16","author":"Wang","year":"2015","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.gene.2026.150236_b0415","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.omtn.2021.07.003","article-title":"hsa_circ_0068631 promotes breast cancer progression through c-Myc by binding to EIF4A3","volume":"26","author":"Wang","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"Pt 2","key":"10.1016\/j.gene.2026.150236_b0740","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.semcancer.2022.03.018","article-title":"RNA-binding proteins and cancer metastasis","volume":"86","author":"Wang","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.gene.2026.150236_b0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ddr.22069","article-title":"Circular RNAs in the chemoresistance of triple-negative breast cancer: A systematic review","volume":"84","author":"Wang","year":"2023","journal-title":"Drug Dev. Res."},{"issue":"5","key":"10.1016\/j.gene.2026.150236_b0695","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3892\/ol.2023.13782","article-title":"Prognostic value of circWWC3 as a novel survival\u2011related biomarker for clear cell renal cell carcinoma","volume":"25","author":"Wang","year":"2023","journal-title":"Oncol. Lett."},{"issue":"14","key":"10.1016\/j.gene.2026.150236_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34079","article-title":"The circZEB1\/miR-337-3p\/OGT axis mediates angiogenesis and metastasis via O-GlcNAcylation and up-regulating YBX1 in breast cancer","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.gene.2026.150236_b0630","article-title":"circTGFBR2(3-6) acts as an assembly platform for RNA-binding protein IGF2BP3 and TGFBR1 mRNA to enhance breast cancer cell plasticity","author":"Wang","year":"2025","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0660","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11427-024-2946-1","article-title":"circSCAP-encoded SCAP-129aa mediates platinum resistance in triple-negative breast cancer via the PI3K\/AKT pathway","volume":"69","author":"Wang","year":"2026","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0100","doi-asserted-by":"crossref","first-page":"20555","DOI":"10.1038\/s41598-024-71505-0","article-title":"The study on circRNA profiling uncovers the regulatory function of the hsa_circ_0059665\/miR-602 pathway in breast cancer","volume":"14","author":"Wu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150236_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216508","article-title":"A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer","volume":"581","author":"Wu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0250","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1038\/s41598-025-96868-w","article-title":"CircSCD1 inhibits ferroptosis in breast Cancer through stabilizing SCD1 protein via deubiquitinase OTUB1","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gene.2026.150236_b0570","article-title":"circWWC3 enhances the progression of triple-negative breast cancer by interacting with vimentin to regulate the secretion of CSF2","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0105","doi-asserted-by":"crossref","first-page":"17765","DOI":"10.1038\/s41598-022-21877-y","article-title":"CircRNA expression profiles of breast cancer and construction of a circRNA-miRNA-mRNA network","volume":"12","author":"Xu","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.gene.2026.150236_b0465","article-title":"A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response","volume":"5","author":"Xu","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.gene.2026.150236_b0685","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18733","article-title":"The role of circRNA in breast cancer drug resistance","volume":"12","author":"Yang","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.gene.2026.150236_b0065","article-title":"Sun C: ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies","volume":"162","author":"Yang","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0470","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0315","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1186\/s12967-025-06794-8","article-title":"Hypoxic cancer-associated fibroblast exosomal circSTAT3drives triple negative breast cancer stemness via miR-671-5p\/NOTCH1 signaling","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0500","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ccell.2024.11.008","article-title":"Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.gene.2026.150236_b0445","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2420383122","article-title":"A circRNA-mRNA pairing mechanism regulates Tumor growth and endocrine therapy resistance in ER-positive breast cancer","volume":"122","author":"Yi","year":"2025","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150236_b0730","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cca.2017.10.011","article-title":"Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection","volume":"487","author":"Yin","year":"2018","journal-title":"Clinica Chimica Acta; Int. J. Clinical Chem."},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0325","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70205","article-title":"Circ_0022587 Regulates Tumor Properties of Human Breast Cancer Cells by Targeting miR-335-5p\/Phosphoglycerate Kinase 1 Pathway","volume":"39","author":"Yin","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"6","key":"10.1016\/j.gene.2026.150236_b0655","first-page":"1697","article-title":"EMT related circular RNA expression profiles identify circSCYL2 as a novel molecule in breast tumor metastasis","volume":"45","author":"Yuan","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.gene.2026.150236_b0650","article-title":"circSCYL2 antagonizes hnRNPA2B1-mediated m6A-chromatin crosstalk to promote ferroptosis and inhibit metastasis of breast cancer to brain","volume":"149699","author":"Yuan","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0200","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1038\/s41598-022-25072-x","article-title":"CD24-associated ceRNA network reveals prognostic biomarkers in breast carcinoma","volume":"13","author":"Yu","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0320","doi-asserted-by":"crossref","first-page":"31501","DOI":"10.1038\/s41598-025-17372-9","article-title":"LRRC75A-AS1 facilitates breast cancer cell proliferation and invasion via functioning as a CeRNA to modulate miR489-3p\/ARD1","volume":"15","author":"Yu","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12282-017-0793-9","article-title":"CircRNA: a novel type of biomarker for cancer","volume":"25","author":"Zhang","year":"2018","journal-title":"Breast Cancer (tokyo, Japan)"},{"issue":"12","key":"10.1016\/j.gene.2026.150236_b0410","first-page":"5315","article-title":"CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt\/\u03b2-catenin pathway","volume":"23","author":"Zhang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.gene.2026.150236_b0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2021.09.013","article-title":"circRNA-miRNA-mRNA in breast cancer","volume":"523","author":"Zhang","year":"2021","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.gene.2026.150236_b0255","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.18632\/aging.202608","article-title":"Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p\/STAT3 axis in breast cancer","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12957-022-02842-5","article-title":"circRNAs and their relationship with breast cancer: A review","volume":"20","author":"Zhang","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","article-title":"Exosomal circRNA: emerging insights into cancer progression and clinical application potential","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.gene.2026.150236_b0430","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1759-7714.14820","article-title":"Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR-6838-5p","volume":"14","author":"Zhang","year":"2023","journal-title":"Thorac Cancer"},{"issue":"5","key":"10.1016\/j.gene.2026.150236_b0540","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006230","article-title":"The NR_109\/FUBP1\/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"12","key":"10.1016\/j.gene.2026.150236_b0545","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41419-023-06383-x","article-title":"TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.gene.2026.150236_b0185","doi-asserted-by":"crossref","DOI":"10.1111\/iwj.14723","article-title":"Assessing biomarkers for post-surgical wound healing: A meta-analysis of exosome-based CircRNA in breast cancer recovery","volume":"21","author":"Zhang","year":"2024","journal-title":"Int. Wound J."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0290","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1038\/s41467-024-49875-w","article-title":"O-GlcNAcylation of MITF regulates its activity and CDK4\/6 inhibitor resistance in breast cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0520","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ccell.2025.01.007","article-title":"Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer","volume":"43","author":"Zhang","year":"2025","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.gene.2026.150236_b0390","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10565-021-09661-6","article-title":"Suspension state and shear stress enhance breast tumor cells EMT through YAP by microRNA-29b","volume":"39","author":"Zhao","year":"2023","journal-title":"Cell Biol. Toxicol."},{"issue":"13","key":"10.1016\/j.gene.2026.150236_b0550","article-title":"M2-like TAMs function reversal contributes to breast cancer eradication by combination dual immune checkpoint blockade and photothermal therapy","volume":"17","author":"Zhao","year":"2021","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.gene.2026.150236_b0130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7150\/ijms.71840","article-title":"Advances in circular RNA and its applications","volume":"19","author":"Zhao","year":"2022","journal-title":"Int. J. Med. Sci."},{"issue":"4","key":"10.1016\/j.gene.2026.150236_b0345","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70249","article-title":"Circ_0038632 acts as a sponge of miR-4306 to facilitate breast cancer progression through regulating CXCR4 expression","volume":"39","author":"Zhao","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"Pt 2","key":"10.1016\/j.gene.2026.150236_b0575","article-title":"Circ_0057582 inhibits breast cancer progression via hnRNPF\/YAP\/SOX9 axis and M2 polarization in TAMs by autophagic degradation of ISG15","volume":"243","author":"Zhao","year":"2026","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0700","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12935-022-02686-9","article-title":"Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4","volume":"22","author":"Zheng","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.gene.2026.150236_b0395","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00432-023-05599-w","article-title":"Propranolol inhibits EMT and metastasis in breast cancer through miR-499-5p-mediated Sox6","volume":"150","author":"Zheng","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","article-title":"Circular RNA: metabolism, functions and interactions with proteins","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"D1","key":"10.1016\/j.gene.2026.150236_b0260","doi-asserted-by":"crossref","first-page":"D571","DOI":"10.1093\/nar\/gkac935","article-title":"FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations","volume":"51","author":"Zhou","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.gene.2026.150236_b0295","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1158\/0008-5472.CAN-24-2492","article-title":"Stabilization of RUNX1 induced by O-GlcNAcylation promotes PDGF-BB-mediated resistance to CDK4\/6 inhibitors in breast cancer","volume":"85","author":"Zhou","year":"2025","journal-title":"Cancer Res."},{"issue":"49","key":"10.1016\/j.gene.2026.150236_b0560","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1038\/s41388-025-03627-2","article-title":"Circular RNA CLASP1 modulates the GLI1\/SNAIL axis and enhances macrophage polarization in breast cancer","volume":"44","author":"Zhou","year":"2025","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.gene.2026.150236_b0625","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ncrna.2023.12.005","article-title":"Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer","volume":"9","author":"Zhu","year":"2024","journal-title":"Noncoding RNA Res"},{"key":"10.1016\/j.gene.2026.150236_b0195","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.19063","article-title":"Development of a prognostic model based on the ceRNA network in triple-negative breast cancer","volume":"13","author":"Zhu","year":"2025","journal-title":"PeerJ"},{"issue":"19","key":"10.1016\/j.gene.2026.150236_b0555","doi-asserted-by":"crossref","first-page":"23169","DOI":"10.18632\/aging.203609","article-title":"LncRNA-SNHG1 promotes macrophage M2-like polarization and contributes to breast cancer growth and metastasis","volume":"13","author":"Zong","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gene.2026.150236_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101126","article-title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer","volume":"77","author":"Zou","year":"2024","journal-title":"Drug Resist. Updat."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:22:26Z","timestamp":1782404546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926002465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":149,"alternative-id":["S0378111926002465"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150236","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circular RNA\u2013centered regulatory networks in breast cancer: From ceRNA crosstalk to immune microenvironment reprogramming","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150236"}}